BGM

BGM Group Ltd. (BGM)

Market Closed
8 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
6. 63
-0.37
-5.29%
$
1.51B Market Cap
- P/E Ratio
0.2% Div Yield
12,780 Volume
- Eps
$ 7
Previous Close
Day Range
6.52 6.82
Year Range
6.5 17.17
Want to track BGM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 44 days

Summary

BGM closed today lower at $6.63, a decrease of 5.29% from yesterday's close, completing a monthly decrease of -1.04% or $0.07. Over the past 12 months, BGM stock lost -25.84%.
BGM pays dividends to its shareholders, with the most recent payment made on Mar 06, 2023. The next estimated payment will be in 6 Mar 2023 on Mar 06, 2023 for a total of $0.25.
The last earnings report, released on Jul 24, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jan 22, 2026.
BGM Group Ltd. has completed 1 stock splits, with the recent split occurring on Jun 21, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

BGM Chart

Similar

NEWEGG COMMERCE INC
$ 68.71
-7.22%
XPEL, Inc.
$ 48.97
-0.43%
Evolv Technologies Holdings, Inc.
$ 6.59
-1.2%
Real Brokerage Inc.
$ 3.97
+2.32%
TH
Target Hospitality Corp.
$ 8.44
+2.43%

BGM Group Ltd. (BGM) FAQ

What is the stock price today?

The current price is $6.63.

On which exchange is it traded?

BGM Group Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is BGM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.2%.

What is its market cap?

As of today, the market cap is 1.51B.

When is the next earnings date?

The next earnings report will release on Jan 22, 2026.

Has BGM Group Ltd. ever had a stock split?

BGM Group Ltd. had 1 splits and the recent split was on Jun 21, 2024.

BGM Group Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Chen Xin CEO
NASDAQ (CM) Exchange
KYG7307E1237 ISIN
CN Country
298 Employees
- Last Dividend
21 Jun 2024 Last Split
- IPO Date

Overview

Qilian International Holding Group Limited is recognized for its expertise in manufacturing and distributing a wide range of products within China, particularly in the pharmaceutical sector. Founded in 2019 and headquartered in Jiuquan, People's Republic of China, the company focuses on producing active pharmaceutical ingredients (APIs), derivatives of traditional Chinese medicine (TCMD), and various other by-products. Its product lineup, primarily centered around licorice products and oxytetracycline tablets, caters to both human health and veterinary uses, illustrating the diversity in its manufacturing capabilities.

Products and Services

  • Gan Di Xin - An antitussive and expectorant medicine derived from licorice, designed to alleviate cough and help in the expulsion of mucus from the air passages.
  • Qilian Shan Licorice Extract - A pure extract from Qilian Shan licorice, used by pharmaceutical companies as a key ingredient in the production of traditional licorice tablets, highlighting its importance in medication manufacturing.
  • Qilian Shan Licorice Liquid Extract - Serving as a primary ingredient for medical preparation companies, this liquid extract is utilized to produce compound licorice oral solutions, demonstrating its versatility in different medicinal forms.
  • Qilian Shan Oxytetracycline Tablets - These tablets are developed to prevent and treat a variety of diseases in chickens, turkeys, cattle, swine, and humans, reflecting the company’s commitment to providing solutions across a broad spectrum of health concerns.
  • Qilian Shan Oxytetracycline APIs - These active pharmaceutical ingredients are supplied to pharmaceutical companies for the creation of oxytetracycline-based medications, underscoring the company's role in supporting the broader pharmaceutical industry.
  • Ahan Antibacterial Paste - A traditional Chinese medicine derivative formulated to treat refractory chronic skin diseases, showcasing the company's dedication to combining modern techniques with traditional remedies.
  • Heparin Products - This range includes heparin sodium preparations for pharmaceutical companies to utilize in creating medications aimed at treating cardiovascular and cerebrovascular diseases, and in hemodialysis procedures.
  • Zhu Xiaochang Sausage Casings - Representing a departure from the pharmaceuticals, these natural food products are intended for culinary applications, emphasizing the company’s diverse product offerings.
  • Xiongguan Organic Fertilizers - These fertilizers are designed to improve crop yield, the chemical properties of soil, and reduce soil compaction, illustrating the company’s engagement in agriculture-enhancing products.
  • Xiongguan Organic-Inorganic Compound Fertilizers - Created to enhance plant growth, these fertilizers showcase the company’s commitment to supporting agricultural productivity through innovative solutions.

Contact Information

Address: No. 152 Hongliang East 1st Street
Phone: 86 28 6477 5180